BioLineRx to Report First Quarter 2025 Results on May 27, 2025

Go back to BioLineRx to Report First Quarter 2025 Results on May 27, 2025
BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.93 --0 (-0%)
Previous Close $2.93    52 Week High $1.63 
Open $2.93    52 Week Low $0.71 
Day High $2.93    P/E N/A 
Day Low $2.93    EPS $0.00 
Volume 11       

BIOLINE RX SP ADR (NASDAQ: BLRX) Delayed: 2.93 --0 (-0%)
Previous Close $2.93    52 Week High $1.63 
Open $2.93    52 Week Low $0.71 
Day High $2.93    P/E N/A 
Day Low $2.93    EPS $0.00 
Volume 11